Conference Overview

Key Highlights

Who should attend the conference


There are plenty of opportunities to position yourself as a thought leader & showcase your company.

For enquiries on speaker opportunities please e-mail to

Day 1 -

Tuesday - 20th March 2018


  • 08:30
  • Registration & Refreshments

  • 09:20
  • Chairperson's opening remarks


  • 09:30
  • A multi-layered approach is the way to go for optimal brand protection 

    • Develop a strategy protecting the patient safety, brand reputation, intellectual property rights and revenue
    • Guidelines to prevent counterfeit from entering the supply chain
    • Monitoring the complex counterfeiters threatening enforcement efforts
    • Create a team which has experts from Law enforcement, supply chain, packaging technology and legal
    • Develop best practices for counterfeit detection, prevention and deterrence
    • Develop & implement a counterfeit risk assessment tool
  • 10:00
  • Worldview of Counterfeit drugs - The evolving counterfeit challenges

    • The common Anti-counterfeiting strategies in EU, US and the rest of the world to handle the counterfeit medicines
    • Identification of countries severely affected by the counterfeit medicines
    • The challenges of combating counterfeit medicines in most affected countries
    • The loopholes in various legislations encouraging gray market to thrive
  • 10:30
  • Morning Coffee/Tea & Networking

  • 10:50
  • The growing market of anti-counterfeiting technologies - Combating counterfeits and illegal trade of drugs

    • Securing the legitimate supply chain of products to avoid organized crimes using anti- counterfeiting technologies
    • Internet is a complete game changer- How to combat cybercrime and illegal online pharmacies?
    • Details on technologies which provides overt and covert features to enable verification of drugs
  • 11:20
  • Is your organization ready for DSCSA, EU FMD and Other Global Regulations?

    • How to define and successfully implement your strategy for global regulatory
    • Identyfying and Implementing the new traceability and interoperability capabilities
    • Aligning with global standards


  • 11:50
  • Advancement in IP enforcement in Europe and what’s next?

    • New EU initiatives to counter growing IPR infringement and counterfeits
    • Reducing Intellectual Property Crime through Effective Partnerships
    • Intellectual property rights (IPR) laid down by the World Intellectual Property Organisation(WIPO)
    • Brexit: English Intellectual Property law implications
  • 12:20
  • Networking & Luncheon

  • 13:30
  • The New EU FMD Requirements - Delegated Regulation on the Anti- Counterfeiting Directive

    Regulations such as EU 2016/161, which has to be implemented by February 9, 2019, require innovative solutions to protect patients against falsified medicines.

    • Technical and Organizational challenges related to the implementation of the EU Directive
    • What are the required safety features in the new directive and ways to implement it at the European Union level and in Member States?
    • Challenges for stakeholders and governments in implementing the safety features of medicinal products
  • 14:00
  • Government regulations, initiatives, policies and strategies to protect the Pharma Industry against Counterfeiting:

    • State of Implementation of the policies
    • Challenges of policies in place
    • Latest developments to improve the security
    • Harmonized regulations and strong leadership can help combat counterfeiting and improve patient safety

  • 14:30
  • Sensitizing the public about the counterfeit Pharma products to curb the sale of Counterfeits

    • Educating the public on the harmful nature of counterfeit medicines and how to identify and avoid them
    • The use of social media as a tool to reach
    • Organizing workshops & seminars to showcase real case examples
  • 15:00
  • Afternoon Tea/Coffee

  • 15:30
  • Combating the rise of global online pharmacies - Are we underestimating the threat?

    • Approaches to authenticate the online pharmacy
    • Will E.U.’s Falsified Medicines Directive help in controlling the interent pharmacies?
    • Improved regulation of online pharmacy market
    • Educating the public on what falsified medicines are and the risks that they pose
    • Collaboration and coordination of multiple stakeholders through out the supply chain
    • A public–private partnership model
  • 16:00
  • Panel Discussion: Creating a joint anti-counterfeiting approach - Enhancing a coherent relationship between all stakeholders of both private and public sector

    To fight against product counterfeiting, the brand owners, law enforcement agencies, industry associations, service providers, government agencies and others should come together sharing their ideas and perspective

    • What needs to be done to collaborate at all levels – Regional, National and International
    • Harmonizing the legal framework for anti-counterfeiting and anti-piracy
    • How are Interpol, Europol and the United Nations Office of Drugs and Crime are fighting against counterfeiting?
    • Role of the international organizations (WHO, WIPO, WTO etc.) in preventing the counterfeit medicines entry into the world markets
  • 16:50
  • Chairperson’s closing remarks

  • 17:00
  • Networking Drinks Session

Delegate Registration

Corvus Global Events recognises the value of learning in teams. There's so much great content!!!

Bring your team and get an extra discount. There are special group packages available. Please email to delegate@corvusglobalevents.comfor more details.


Maximise Your Involvement through Sponsorship and Exhibition Opportunities Our Sponsors are an integral part of the CGE Conference and we want to ensure you receive the best possible results for your investment. Exhibiting and Sponsorship options are extensive, and packages can be tailor-made to suit your individual company's needs. Most packages include complimentary entry passes, targeted marketing to industry officials and executives, and bespoke networking opportunities.

For enquiries please e-mail to


EXTEDO's focus is on optimizing clients' eRegulatory business processes. The company's enabling technology, the EXTEDOsuite, is uniquet in that it covers the complete regulatory landscape including:Product Registration Planning & Tracking (XEVMPD & IDMP)Submission Publishing & Lifecycle Management (eCTD, CTD, NeeS, IMPD, CTA, eCopy, DMF, ASMF, VNeeS, CADDY, ePRISM, eIndex) Pharmacovigilance Management (SUSAR, ICSR, PSUR, E2B, MedDRA, SMQ, GvP, CIOMS, MedWatch, R3) andDocument Management
We offer configurable off-the-shelf products, as well as customized and integrated solutions compliant with Medical Product Dictionary. EXTEDO also provides EURS, the validation, review and approval software solution for the EMA and over 25 Regulatory Authorities worldwide. Today we serve more than 700 customers in 60 countries ranging from small companies to large multinational organizations. EXTEDO operates in the following areas of life sciences: pharmaceutical, biotech and biopharma, generics, homeopathics, medical devices, crop sciences and public sector. EXTEDO is recognized as one of the worldwide leaders in each of these areas of operation.


Partnerships typically involve an exchange of value and frequently include online content, PR, advertising, online & event branding.

For enquiries please e-mail to



Hotel TBC, Singapore

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now